References
- Magliano DJ, Peeters A, Vos T, et al. Projecting the burden of diabetes in Australia–what is the size of the matter? Aust N Z J Public Health. 2009;33:540–543.
- Rowley WR, Bezold C, Arikan Y, et al. Diabetes 2030: insights from yesterday, today, and future trends. Popul Health Manag. 2017;20:6–12.
- Ramli AS, Selvarajah S, Daud MH, et al. Effectiveness of the EMPOWER-PAR intervention in improving clinical outcomes of type 2 diabetes mellitus in primary care: a pragmatic cluster randomised controlled trial. BMC Fam Pract. 2016;17:157.
- Murray CJ, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2013;380:2197–2223.
- International diabetes Federation, IDF Diabetes Atlas 6th, 2015 page 10–14.
- International diabetes federation. Facts and figures. 2017; Available from: www.idf.org/about-diabetes/what-is-diabetes accessed on March 2017.
- Khowaja LA, Khuwaja AK, Cosgrove P. Cost of diabetes care in out-patient clinics of Karachi, Pakistan. BMC Health Serv Res. 2007;7:189.
- Zhang P, Zhang X, Brown J, et al. Global healthcare expenditure on diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87:293–301.
- World Health Organization. “Global report on diabetes.” 2016; 86.
- Caro JJ, Ward AJ, O’Brien JA. Lifetime costs of complications resulting from type 2 diabetes in the. U.S. Diabetes Care. 2002;25:476–481.
- Ali A, Iqbal F, Taj A, et al. Prevalence of microvascular complications in newly diagnosed patients with Type 2 diabetes. Pakistan J Med Sci. 2013;29:899–902.
- Shera AS, Jawad F, Maqsood A, et al. Prevalence of chronic complications and associated factors in type 2 diabetes. JPMA J Pakistan Med Assoc. 2004;54:54–59.
- Ramachandran A, Snehalatha C, Vijay V, et al. Impact of poverty on the prevalence of diabetes and its complications in urban southern India. Diabetes Med. 2002;19:130–135.
- Javanbakht M, Baradaran HR, Mashayekhi A, et al. Cost-of-illness analysis of type 2 diabetes mellitus in Iran. PLoS One. 2011;6:e26864.
- Ul Haq N, Hassali MA, Shafie AA, et al. A cross sectional assessment of knowledge, attitude Eand practice towards hepatitis B among healthy population of Quetta, Pakistan. BMC Public Health. 2012;12:692.
- NgC S, Toh MPHS, Ko Y, et al. Direct medical cost of type 2 diabetes in Singapore. PLoS One. 2015;10:e0122795.
- Mokdad AH, Tuffaha M, Hanlon M, et al. Cost of diabetes in the Kingdom of Saudi Arabia, 2014. J Diabetes Metab. 2015;6:575.
- Pharmacy Guide. Pharmaceutical industries of Pakistan. 24th ed. Karachi, Pakistan: SJ, G Fazal Ellahie; 2016.
- Minimum Wages in Pakistan 2016–17 available at http://www.paycheck.pk/main/salary/minimum-wages. Accessed on 2017 Mar 15
- Duan N. Smearing estimate: a nonparametric retransformation method. J Am Stat Assoc. 1983;78:605–610.
- Historical Rates for the USD/PKR currency conversion on July 2016 available at https://www.poundsterlinglive.com/best-exchange-rates/us-dollar-to-pakistani-rupee-exchange-rate-on-2016-07-31 accessed on March 2017.
- American Diabetes Association. Economic costs of diabetes in the US in 2012. Diabetes Care. 2013;36:1033–1046.
- Wang W, McGreevey WP, Fu C, et al. Type 2 diabetes mellitus in China: a preventable economic burden. Am J Manag Care. 2009;15:593–601.
- Tharkar S, Devarajan A, Kumpatla S, et al. The socioeconomics of diabetes from a developing country: a population based cost of illness study. Diab Res Clin Pract. 2010;89:334–340.
- Ramachandran A, Ramachandran S, Snehalatha C, et al. Increasing expenditure on health care incurred by diabetic subjects in a developing country. Diabetes Care. 2007;30:252–256.
- Population of Pakistan (2017 and historical) available at http://www.worldometers.info/world-population/pakistan-population/. Accessed on March 2017.
- Ali S. Budget 2016–2017 Published June 3, 2016. Available at https://en.dailypakistan.com.pk/headline/live-finance-minister-unveils-budget-for-2016-2017/. Accessed on 2017 Apr 1
- Shobhana R, Rama Rao P, Lavanya A, et al. Expenditure on health care incurred by diabetic subjects in a developing country–a study from southern India. Diab Res Clin Pract. 2000;48:37–42.
- Grover S, Avasthi A, Bhansali A, et al. Cost of ambulatory care of diabetes mellitus: a study from north India. Postgrad Med J. 2005;81:391–395.
- Quaye EA, Amporful EO, Akweongo P, et al. Analysis of the financial cost of diabetes mellitus in four Cocoa clinics of Ghana. Value Health Regional Issues. 2015;7:49–53.
- Dawson KG, Gomes D, Gerstein H, et al. The economic cost of diabetes in Canada, 1998. Diabetes Care. 2002;25:1303–1307.
- Ba¨Chle C, Icks A, Straßburger K, et al. Direct diabetes-related costs in young patients with early-onset, long lasting type 1 diabetes. PLoS One. 2013;8:e70567.
- Ament A, Evers S. Cost of illness studies in health care: a comparison of two cases. Health Policy (New York). 1993;26:29–42.
- Ibrahim WN, Aljunid S, Ismail A. Cost of type 2 diabetes mellitus in selected developing countries. Malaysian J Public Health Med. 2010;10:68–71.
- González JC, Walker JH, Einarson TR. Cost-of-illness study of type 2 diabetes mellitus in Colombia. Rev Panam Salud Publica. 2009;26:55–63.
- Boutayeb W, Lamlili MEN, Boutayeb A, et al. Estimation of direct and indirect cost of diabetes in Morocco. J Biomed Sci Eng. 2013;6:732.